Detection Rates of High-risk Human Papilloma Virus in Women with Abnormal Cervical Cytology: A Comparison between Self-collected and Physician-collected Specimens

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20220826006

Enrollment

500

Registered

2022-08-26

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Intraepithelial Neoplasia HPV, self sampling, cervical cancer screening, cervical cancer prevention

Interventions

Self sampling HPV testing

Experimental Device

Self sampling HPV

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: age 18 or more abnormal cytology or hpv hr positive agree to participate

Exclusion criteria

Exclusion criteria: pregnancy history of cervical cancer or hysterectomy history of radiation therapy

Design outcomes

Primary

Measure	Time frame
Self sampling HPV at the end of the study HPV testing	—

Secondary

Measure	Time frame
Knowledge and attitude at the end of the study questionnaire interview	—

Countries

Thailand

Contacts

Public ContactNatacha Phoolcharoen

Faculty of Medicine, Chulalongkorn University

phnatacha@hotmail.com0814883707

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026